BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10072348)

  • 21. Eyelid dermatitis: a report of 215 patients.
    Guin JD
    Contact Dermatitis; 2004 Feb; 50(2):87-90. PubMed ID: 15128319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of patch testing patients with a scattered generalized distribution of dermatitis: retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004.
    Zug KA; Rietschel RL; Warshaw EM; Belsito DV; Taylor JS; Maibach HI; Mathias CG; Fowler JF; Marks JG; DeLeo VA; Pratt MD; Sasseville D; Storrs FJ
    J Am Acad Dermatol; 2008 Sep; 59(3):426-31. PubMed ID: 18597890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use and abuse of topical corticosteroids in infections of the skin and related structures.
    Wong VK; Della Croce C; Schonfeld S; Mastrangelo AM; Lebwohl M
    J Drugs Dermatol; 2003 Jun; 2(3):268-76. PubMed ID: 12848111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. StabiEL: stabilization of skin condition with Elidel--a patients' satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid.
    Gollnick H; Luger T; Freytag S; Bräutigam M;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1319-25. PubMed ID: 18540990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Throwing a light on photosensitivity in atopic dermatitis: a retrospective study.
    ten Berge O; van Weelden H; Bruijnzeel-Koomen CA; de Bruin-Weller MS; Sigurdsson V
    Am J Clin Dermatol; 2009; 10(2):119-23. PubMed ID: 19222251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Origin and significance of perioral dermatitis (author's transl)].
    Nolting S; Passmann M
    MMW Munch Med Wochenschr; 1977 Jan; 119(2):49-52. PubMed ID: 138081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Batch variations.
    Calnan CD
    Dermatol Clin; 1990 Jan; 8(1):23-5. PubMed ID: 2302860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment.
    Simon D; Vassina E; Yousefi S; Braathen LR; Simon HU
    Allergy; 2005 Jul; 60(7):944-51. PubMed ID: 15932386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oat sensitization in children with atopic dermatitis: prevalence, risks and associated factors.
    Boussault P; Léauté-Labrèze C; Saubusse E; Maurice-Tison S; Perromat M; Roul S; Sarrat A; Taïeb A; Boralevi F
    Allergy; 2007 Nov; 62(11):1251-6. PubMed ID: 17919139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Objective evaluation of the efficacy of daily topical applications of cosmetics bases using the hairless mouse model of atopic dermatitis.
    Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Sakai Y; Tagami H
    Skin Res Technol; 2005 Aug; 11(3):209-17. PubMed ID: 15998334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis.
    Yawalkar N; Karlen S; Egli F; Brand CU; Graber HU; Pichler WJ; Braathen LR
    J Allergy Clin Immunol; 2000 Nov; 106(5):941-7. PubMed ID: 11080718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contact sensitivity and atopic dermatitis: association with prognosis, a follow-up study in 801 atopic patients.
    Mäkelä L; Lammintausta K; Kalimo K
    Contact Dermatitis; 2007 Feb; 56(2):76-80. PubMed ID: 17244074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of atopic dermatitis: practical guidelines suggested by the conclusion of systematic assessment in 500 children].
    Guillet MH; Guillet G;
    Allerg Immunol (Paris); 2000 Oct; 32(8):305-8. PubMed ID: 11244924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance of oat-based topical products in cereal-sensitized adults with atopic dermatitis.
    Goujon C; Jean-Decoster C; Dahel K; Bottigioli D; Lahbari F; Nicolas JF; Schmitt AM
    Dermatology; 2009; 218(4):327-33. PubMed ID: 19223682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical dinitrochlorobenzene therapy in the treatment of refractory atopic dermatitis: systemic immunotherapy.
    Yoshizawa Y; Matsui H; Izaki S; Kitamura K; Maibach HI
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):258-62. PubMed ID: 10642682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formaldehyde allergy: A follow-up study.
    Agner T; Flyvholm MA; Menné T
    Am J Contact Dermat; 1999 Mar; 10(1):12-7. PubMed ID: 10072333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).
    Eberlein B; Eicke C; Reinhardt HW; Ring J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):73-82. PubMed ID: 18181976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of dermatoses associated with cosmetics.
    Duarte I; Campos Lage AC
    Contact Dermatitis; 2007 Apr; 56(4):211-3. PubMed ID: 17343621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.